Arie Belldegrun Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

DNA Quotes by TradingView

Arie Belldegrun is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 194,925 shares of DNA, which is worth approximately $1.99 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 105,263 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 195K
0% 3M change
117.4% 12M change
Total Value Held $1.99 Million

Arie Belldegrun Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
105,263 Added 35.07%
194,925 Class A Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
70,921 Added 44.16%
89,662 Class A Common Stock

Also insider at

KRON
Kronos Bio, Inc. Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
Director
URGN
UroGen Pharma Ltd. Healthcare
Director
AB

Arie Belldegrun

Director
Princeton, NJ

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNA